Abstract:The spectrum of neurodevelopmental outcomes for children born during the COVID-19 pandemic with either antenatal exposure to maternal SARS-CoV-2 infection or early postnatal SARS-CoV-2 infection continues to be an area of uncertainty and of important ingoing investigations. Rebecca Jackson and colleagues conducted a systematic review to assess the impact of antenatal or neonatal exposure to SARS-CoV-2 on neurodevelopmental outcomes in infancy in both infants born preterm and those born at term. 1 Studies conducted to date have varied in their findings on the effects to neurodevelopmental outcomes, but many of these studies are limited by not having a control group of non-exposed infants, only including infants born to mothers asymptomatic or with low symptom severity, or by not analyzing preterm and term infant outcomes separately. 1 Preterm newborns may have greater vulnerability to adverse neurodevelopmental outcomes, and preterm birth can be the outcome of complicated pregnancies with viral infection; thus, it is commendable the effort of Jackson and colleagues to assess the effect of SARS-CoV-2 early life exposure taking into account the role of preterm birth. Despite multiple cohort studies being conducted over the last several years assessing infant outcomes following SARS-CoV-2 exposure, only five studies met the inclusion criteria for the systematic review since many did not include a contemporaneous non-exposed control group. 1 Unfortunately, the authors did not include in their analysis well-powered samples where the effect of in utero exposure on risk for neurodevelopmental disorders was assessed using electronic health records, which can provide helpful information to understand outcomes. 2 The systematic review by Jackson and colleagues found studies to be inconsistent in their findings and overall, in term-born infants a difference in neurodevelopment during infancy was not seen, and in preterm-born infants, too few were reported to have a meaningful conclusion. 1 However, some of the reported effect sizes are not negligible, and the confidence intervals are consistent with the possibility of an important effect of antenatal exposure to SARS-CoV-2 on neurodevelopmental outcomes in a subset of infants. For example, among term-born infants the odds ratio (OR) associated with viral exposure is 2.90 for fine motor development, with 14.43 as the upper confidence interval. 1 It is therefore desirable that similar studies should not base their conclusions only on a significance threshold and should include an analysis of the effect of the exposure on the variance of the outcome, to identify a subset of infants with a possible deleterious effect of the exposure. This systematic review indicates a need for additional studies of preterm and term infants and for longer term outcomes following antenatal or neonatal SARS-CoV-2 exposure. However, the findings by Jackson and colleagues, as any findings of impacts or lack of impact on infant neurodevelopment following early-in-life exposure to SARS-CoV-2 infection must be interpreted with caution.

Early life exposure to SARS-CoV-2 and offspring neurodevelopment: detecting a non-linear relationship requires a complex approach